Dr. Al Hussein is a board-certified urologic cancer surgeon who specializes in the diagnosis and management of genitourinary malignancies, including prostate, kidney, bladder, testicular and penile cancers. He provides comprehensive cancer care using both robotic and open surgical approaches, tailored to the complexity and stage of each patient's disease. His expertise includes minimally invasive robotic procedures - such as radical prostatectomy, partial nephrectomy and cystectomy - as well as retroperitoneal lymph node dissection (RPLND) for testicular cancer and complex open operations for advanced or anatomically challenging tumors.

Dr. Al Hussein's research program applies epidemiologic methods to treatment decision-making in prostate cancer, with an emphasis on long-term outcomes, survivorship and health literacy. His work has been published in leading journals including The Journal of the American Medical Association (JAMA), The New England Journal of Medicine, JAMA Oncology and JAMA Internal Medicine. He is a recipient of the Prostate Cancer Foundation Young Investigator Award and the American Urological Association Research Scholar Award, and serves as Director of the Adult Urology Clinic within the Department of Urology at Weill Cornell Medicine.

Dr. Bashir Al Hussein is a Urologic Oncologist and Assistant Professor of Urology at Weill Cornell Medicine and NewYork-Presbyterian Hospital. He completed his urology residency at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a Society of Urologic Oncology (SUO) fellowship at Vanderbilt University Medical Center. He also holds a Master of Public Health in Epidemiology from Vanderbilt University and earned his medical degree from the University of Jordan in Amman.